<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38279329</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Microbiota in Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1330</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25021330</ELocationID><Abstract><AbstractText>Interest in the coronavirus disease 2019 (COVID-19) has progressively decreased lately, mainly due to the great effectivity of vaccines. Furthermore, no new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants able to circumvent the protection of these vaccines, while presenting high transmissibility and/or lethality, have appeared. However, long COVID has emerged as a huge threat to human health and economy globally. The human microbiota plays an important role in health and disease, participating in the modulation of innate and adaptive immune responses. Thus, multiple studies have found that the nasopharyngeal microbiota is altered in COVID-19 patients, with these changes associated with the onset and/or severity of the disease. Nevertheless, although dysbiosis has also been reported in long COVID patients, mainly in the gut, little is known about the possible involvement of the microbiota in the development of this disease. Therefore, in this work, we aim to fill this gap in the knowledge by discussing and comparing the most relevant studies that have been published in this field up to this point. Hence, we discuss that the relevance of long COVID has probably been underestimated, and that the available data suggest that the microbiota could be playing a pivotal role on the pathogenesis of the disease. Further research to elucidate the involvement of the microbiota in long COVID will be essential to explore new therapeutic strategies based on manipulation of the microbiota.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xc1;lvarez-Santacruz</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Otorrinolaringolog&#xed;a, Hospital de la Vega Lorenzo Guirao, 30530 Cieza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyrkalska</LastName><ForeName>Sylwia D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-6654-0163</Identifier><AffiliationInfo><Affiliation>Departamento de Biolog&#xed;a Celular e Histolog&#xed;a, Facultad de Biolog&#xed;a, Universidad de Murcia, 30100 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Murciano de Investigaci&#xf3;n Biosanitaria (IMIB)-Pascual Parrilla, 30120 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candel</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7919-6584</Identifier><AffiliationInfo><Affiliation>Departamento de Biolog&#xed;a Celular e Histolog&#xed;a, Facultad de Biolog&#xed;a, Universidad de Murcia, 30100 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Murciano de Investigaci&#xf3;n Biosanitaria (IMIB)-Pascual Parrilla, 30120 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>00006/COVI/20</GrantID><Agency>Fundaci&#xf3;n S&#xe9;neca - Agencia de Ciencia y Tecnolog&#xed;a de la Regi&#xf3;n de Murcia</Agency><Country/></Grant><Grant><GrantID>21118/SF/19</GrantID><Agency>Fundaci&#xf3;n S&#xe9;neca - Agencia de Ciencia y Tecnolog&#xed;a de la Regi&#xf3;n de Murcia</Agency><Country/></Grant><Grant><GrantID>Juan de la Cierva-Incorporaci&#xf3;n</GrantID><Agency>Ministerio de Ciencia e Innovaci&#xf3;n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dysbiosis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microbiota</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>27</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>27</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38279329</ArticleId><ArticleId IdType="pmc">PMC10816132</ArticleId><ArticleId IdType="doi">10.3390/ijms25021330</ArticleId><ArticleId IdType="pii">ijms25021330</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157&#x2013;160. doi: 10.23750/abm.v91i1.9397.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Soheili M., Khateri S., Moradpour F., Mohammadzedeh P., Zareie M., Mortazavi S.M.M., Manifar S., Kohan H.G., Moradi Y. The efficacy and effectiveness of COVID-19 vaccines around the world: A mini-review and meta-analysis. Ann. Clin. Microbiol. Antimicrob. 2023;22:42. doi: 10.1186/s12941-023-00594-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-023-00594-y</ArticleId><ArticleId IdType="pmc">PMC10198032</ArticleId><ArticleId IdType="pubmed">37208749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Shao W., Chen X., Zhang B., Wang G., Zhang W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2022;114:252&#x2013;260. doi: 10.1016/j.ijid.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. COVID-19: WHO declares end of global health emergency. BMJ. 2023;381:1041. doi: 10.1136/bmj.p1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p1041</ArticleId><ArticleId IdType="pubmed">37160309</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Long COVID or Post-COVID Conditions. CDC; Atlanta, GA, USA: 2022.</Citation></Reference><Reference><Citation>Marchesi J.R., Ravel J. The vocabulary of microbiome research: A proposal. Microbiome. 2015;3:31. doi: 10.1186/s40168-015-0094-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-015-0094-5</ArticleId><ArticleId IdType="pmc">PMC4520061</ArticleId><ArticleId IdType="pubmed">26229597</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium H.M.P. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207&#x2013;214. doi: 10.1038/nature11234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11234</ArticleId><ArticleId IdType="pmc">PMC3564958</ArticleId><ArticleId IdType="pubmed">22699609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z.X., Chen X.Y., Wang J.Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S.V., Pedersen O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 2016;375:2369&#x2013;2379. doi: 10.1056/NEJMra1600266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubourg G., Edouard S., Raoult D. Relationship between nasopharyngeal microbiota and patient&#x2019;s susceptibility to viral infection. Expert Rev. Anti-Infect. Ther. 2019;17:437&#x2013;447. doi: 10.1080/14787210.2019.1621168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2019.1621168</ArticleId><ArticleId IdType="pubmed">31106653</ArticleId></ArticleIdList></Reference><Reference><Citation>Candel S., Tyrkalska S.D., &#xc1;lvarez-Santacruz C., Mulero V. The nasopharyngeal microbiome in COVID-19. Emerg. Microbes Infect. 2023;12:e2165970. doi: 10.1080/22221751.2023.2165970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2165970</ArticleId><ArticleId IdType="pmc">PMC9869994</ArticleId><ArticleId IdType="pubmed">36606725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Price J., Abu-Ali G., Huttenhower C. The healthy human microbiome. Genome Med. 2016;8:51. doi: 10.1186/s13073-016-0307-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0307-y</ArticleId><ArticleId IdType="pmc">PMC4848870</ArticleId><ArticleId IdType="pubmed">27122046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet. 2003;361:512&#x2013;519. doi: 10.1016/S0140-6736(03)12489-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12489-0</ArticleId><ArticleId IdType="pubmed">12583961</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients with COVID-19 during Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin-Yilmaz A., Naclerio R.M. Anatomy and physiology of the upper airway. Proc. Am. Thorac. Soc. 2011;8:31&#x2013;39. doi: 10.1513/pats.201007-050RN.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.201007-050RN</ArticleId><ArticleId IdType="pubmed">21364219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitzenbichler F., Bauernfeind S., Salzberger B., Schmidt B., Wenzel J.J. Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2. Viruses. 2021;13:653. doi: 10.3390/v13040653.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040653</ArticleId><ArticleId IdType="pmc">PMC8069237</ArticleId><ArticleId IdType="pubmed">33920072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., O&#x2019;Leary T.J. Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis. PLoS ONE. 2021;16:e0254559. doi: 10.1371/journal.pone.0254559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254559</ArticleId><ArticleId IdType="pmc">PMC8291630</ArticleId><ArticleId IdType="pubmed">34283845</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xfc;ce M., Filiztekin E., &#xd6;zkaya K.G. COVID-19 diagnosis&#x2014;A review of current methods. Biosens. Bioelectron. 2021;172:112752. doi: 10.1016/j.bios.2020.112752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2020.112752</ArticleId><ArticleId IdType="pmc">PMC7584564</ArticleId><ArticleId IdType="pubmed">33126180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Sakai-Tagawa Y., Koga M., Akasaka O., Nakachi I., Koh H., Maeda K., Adachi E., Saito M., Nagai H., et al. Comparison of Rapid Antigen Tests for COVID-19. Viruses. 2020;12:1420. doi: 10.3390/v12121420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121420</ArticleId><ArticleId IdType="pmc">PMC7764512</ArticleId><ArticleId IdType="pubmed">33322035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID Conditions among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. Morb. Mortal. Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan P.O., Behan W.M. Postviral fatigue syndrome. Crit. Rev. Neurobiol. 1988;4:157&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">3063394</ArticleId></ArticleIdList></Reference><Reference><Citation>Leviner S. Recognizing the Clinical Sequelae of COVID-19 in Adults: COVID-19 Long-Haulers. J. Nurse Pract. 2021;17:946&#x2013;949. doi: 10.1016/j.nurpra.2021.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.05.003</ArticleId><ArticleId IdType="pmc">PMC8103144</ArticleId><ArticleId IdType="pubmed">33976591</ArticleId></ArticleIdList></Reference><Reference><Citation>Baj J., Karaku&#x142;a-Juchnowicz H., Teresi&#x144;ski G., Buszewicz G., Ciesielka M., Sitarz R., Forma A., Karaku&#x142;a K., Flieger W., Portincasa P., et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J. Clin. Med. 2020;9:1753. doi: 10.3390/jcm9061753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061753</ArticleId><ArticleId IdType="pmc">PMC7356953</ArticleId><ArticleId IdType="pubmed">32516940</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R., Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. 2005;55:20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff D., Nee S., Hickey N.S., Marschollek M. Risk factors for COVID-19 severity and fatality: A structured literature review. Infection. 2021;49:15&#x2013;28. doi: 10.1007/s15010-020-01509-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01509-1</ArticleId><ArticleId IdType="pmc">PMC7453858</ArticleId><ArticleId IdType="pubmed">32860214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahi Y., Gorabi A.M., Talaei S., Beiraghdar F., Akbarzadeh A., Tarhriz V., Mellatyar H. An overview on the treatments and prevention against COVID-19. Virol. J. 2023;20:23. doi: 10.1186/s12985-023-01973-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-01973-9</ArticleId><ArticleId IdType="pmc">PMC9906607</ArticleId><ArticleId IdType="pubmed">36755327</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A., Kelly C., Pottinger G., Hopkins C. Parosmia-a common consequence of COVID-19. BMJ. 2022;377:e069860. doi: 10.1136/bmj-2021-069860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069860</ArticleId><ArticleId IdType="pubmed">35477684</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., Cotler J., Torres C., Johnson M., Mabie B. COVID-19 Symptoms Over Time: Comparing Long-Haulers to ME/CFS. Fatigue. 2021;9:59&#x2013;68. doi: 10.1080/21641846.2021.1922140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z., Dautaj A., Nodari S., Fioretti F., Dhuli K., Anpilogov K., Lorusso L., Paolacci S., Michelini S., Guda T., et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur. Rev. Med. Pharmacol. Sci. 2021;25:67&#x2013;73. doi: 10.26355/eurrev_202112_27335.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27335</ArticleId><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R., Trimarco V., Mone P., Alo&#xe8; T., Capra Marzani M., Diana A., Fazio G., Mallardo M., Maniscalco M., Marazzi G., et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacol. Res. 2022;183:106360. doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato M.S., Brilli E., Ferri N., Giordano G., Tarantino G. Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress. Clin. Nutr. ESPEN. 2021;46:510&#x2013;518. doi: 10.1016/j.clnesp.2021.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.08.031</ArticleId><ArticleId IdType="pmc">PMC8420132</ArticleId><ArticleId IdType="pubmed">34857243</ArticleId></ArticleIdList></Reference><Reference><Citation>Barletta M.A., Marino G., Spagnolo B., Bianchi F.P., Falappone P.C.F., Spagnolo L., Gatti P. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clin. Exp. Med. 2023;23:667&#x2013;678. doi: 10.1007/s10238-022-00871-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00871-8</ArticleId><ArticleId IdType="pmc">PMC9395797</ArticleId><ArticleId IdType="pubmed">35994177</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibnhadjamor H., Jdidi J., Torjmen S., Kraiem S., Bahloul A., Makni A., Kallel N., Moussa N., Boudaya M., et al. Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Sun K.Y., Meng T.Q., Ye Z., Guo S.M., Li Z.M., Xiong C.L., Yin Y., Li H.G., Zhou L.Q. Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery. Front. Nutr. 2021;8:638825. doi: 10.3389/fnut.2021.638825.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.638825</ArticleId><ArticleId IdType="pmc">PMC8155354</ArticleId><ArticleId IdType="pubmed">34055851</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay V., Suryawanshi R.K., Tasoff P., McCavitt-Malvido M., Kumar R.G., Murray V.W., Noecker C., Bisanz J.E., Hswen Y., Ha C.W.Y., et al. Mild SARS-CoV-2 infection results in long-lasting microbiota instability. mBio. 2023;14:e0088923. doi: 10.1128/mbio.00889-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00889-23</ArticleId><ArticleId IdType="pmc">PMC10470529</ArticleId><ArticleId IdType="pubmed">37294090</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S., Philip K.E.J., Williams P., Fallas A., West B., Cumella A., Cheung C., Walker S., Quint J.K., Polkey M.I., et al. Patient symptoms and experience following COVID-19: Results from a UK-wide survey. BMJ Open Respir. Res. 2021;8:e001075. doi: 10.1136/bmjresp-2021-001075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001075</ArticleId><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L., Gazit S., Pinto Y., Perez G., Mizrahi Reuveni M., Yehoshua I., Hoffman R., Azuri J., Patalon T. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: A Nationwide Cohort Study. Scand J. Prim. Health Care. 2022;40:342&#x2013;349. doi: 10.1080/02813432.2022.2139480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02813432.2022.2139480</ArticleId><ArticleId IdType="pmc">PMC9848375</ArticleId><ArticleId IdType="pubmed">36314555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Lu H., Shi D., Guo J., Wu W.R., Yang Y., Li Y., Xu K.J., Ding C., et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71:222&#x2013;225. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Zhou Y., Ma Y., Chen P., Tang J., Yang B., Li H., Liang M., Xue Y., Liu Y., et al. Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., Lakshmanan A., Wade W.G. The human oral microbiome. J. Bacteriol. 2010;192:5002&#x2013;5017. doi: 10.1128/JB.00542-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00542-10</ArticleId><ArticleId IdType="pmc">PMC2944498</ArticleId><ArticleId IdType="pubmed">20656903</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano S., Ansai T., Takata Y., Soh I., Akifusa S., Hamasaki T., Yoshida A., Sonoki K., Fujisawa K., Takehara T. Oral health and mortality risk from pneumonia in the elderly. J. Dent. Res. 2008;87:334&#x2013;339. doi: 10.1177/154405910808700418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/154405910808700418</ArticleId><ArticleId IdType="pubmed">18362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Scannapieco F.A. Role of oral bacteria in respiratory infection. J. Periodontol. 1999;70:793&#x2013;802. doi: 10.1902/jop.1999.70.7.793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.1999.70.7.793</ArticleId><ArticleId IdType="pubmed">10440642</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour G.J., Ford P.J., Cullinan M.P., Leishman S., Yamazaki K. Relationship between periodontal infections and systemic disease. Clin. Microbiol. Infect. 2007;13((Suppl. S4)):3&#x2013;10. doi: 10.1111/j.1469-0691.2007.01798.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01798.x</ArticleId><ArticleId IdType="pubmed">17716290</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges F.M., Do N.T., Seleem D. Oral dysbiosis and systemic diseases. Front. Dent. Med. 2022;3:995423. doi: 10.3389/fdmed.2022.995423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdmed.2022.995423</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bradley E., Zeamer A.L., Cincotta L., Salive M.C., Dutta P., Mutaawe S., Anya O., Meza-Segura M., Moormann A.M., et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 2021;6:e152346. doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama S., Takeshita T., Furuta M., Tomioka M., Asakawa M., Suma S., Takeuchi K., Shibata Y., Iwasa Y., Yamashita Y. Relationships of Variations in the Tongue Microbiota and Pneumonia Mortality in Nursing Home Residents. J. Gerontol. A Biol. Sci. Med. Sci. 2018;73:1097&#x2013;1102. doi: 10.1093/gerona/glx205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glx205</ArticleId><ArticleId IdType="pubmed">29053769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammen M.J., Scannapieco F.A., Sethi S. Oral-lung microbiome interactions in lung diseases. Periodontol 2000. 2020;83:234&#x2013;241. doi: 10.1111/prd.12301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12301</ArticleId><ArticleId IdType="pubmed">32385873</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen J.M. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151:363&#x2013;374. doi: 10.1111/imm.12760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12760</ArticleId><ArticleId IdType="pmc">PMC5506432</ArticleId><ArticleId IdType="pubmed">28542929</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal L.N., Clemente J.C., Tsay J.C., Koralov S.B., Keller B.C., Wu B.G., Li Y., Shen N., Ghedin E., Morris A., et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 2016;1:16031. doi: 10.1038/nmicrobiol.2016.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.31</ArticleId><ArticleId IdType="pmc">PMC5010013</ArticleId><ArticleId IdType="pubmed">27572644</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal L.N., Alekseyenko A.V., Clemente J.C., Kulkarni R., Wu B., Gao Z., Chen H., Berger K.I., Goldring R.M., Rom W.N., et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1:19. doi: 10.1186/2049-2618-1-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2049-2618-1-19</ArticleId><ArticleId IdType="pmc">PMC3971609</ArticleId><ArticleId IdType="pubmed">24450871</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bogert B., Meijerink M., Zoetendal E.G., Wells J.M., Kleerebezem M. Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS ONE. 2014;9:e114277. doi: 10.1371/journal.pone.0114277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114277</ArticleId><ArticleId IdType="pmc">PMC4257559</ArticleId><ArticleId IdType="pubmed">25479553</ArticleId></ArticleIdList></Reference><Reference><Citation>Delwiche E.A., Pestka J.J., Tortorello M.L. The veillonellae: Gram-negative cocci with a unique physiology. Annu. Rev. Microbiol. 1985;39:175&#x2013;193. doi: 10.1146/annurev.mi.39.100185.001135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.39.100185.001135</ArticleId><ArticleId IdType="pubmed">3904599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., Chen X., Ren H., Sun R., Liu W., et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty S.A., Marathe N.P., Lanjekar V., Ranade D., Shouche Y.S. Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut. PLoS ONE. 2013;8:e79353. doi: 10.1371/journal.pone.0079353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079353</ArticleId><ArticleId IdType="pmc">PMC3832451</ArticleId><ArticleId IdType="pubmed">24260205</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2018;The long tail of COVID-19&#x2019;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R.M., Solomon S.D., Ridker P.M., Metra M. Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease. J. Am. Heart Assoc. 2020;9:e017756. doi: 10.1161/JAHA.120.017756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017756</ArticleId><ArticleId IdType="pmc">PMC7660796</ArticleId><ArticleId IdType="pubmed">32677478</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Ma Y., Deng J., Liu M., Liu J. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkov V.A., Silachev D.N., Zalevsky A.O., Zorov D.B., Plotnikov E.Y. Mitochondria as a Source and a Target for Uremic Toxins. Int. J. Mol. Sci. 2019;20:3094. doi: 10.3390/ijms20123094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20123094</ArticleId><ArticleId IdType="pmc">PMC6627204</ArticleId><ArticleId IdType="pubmed">31242575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes de Almeida V., Engel D.F., Ricci M.F., Cruz C.S., Lopes &#xcd;., Alves D.A., d&#x2019; Auriol M., Magalh&#xe3;es J., Machado E.C., Rocha V.M., et al. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms. Gut Microbes. 2023;15:2249146. doi: 10.1080/19490976.2023.2249146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2249146</ArticleId><ArticleId IdType="pmc">PMC10481883</ArticleId><ArticleId IdType="pubmed">37668317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M.C.S., Zhang L., Ching J.Y.L., Mak J.W.Y., Huang J., Wang S., Mok C.K.P., Wong A., Chiu O.L., Fung Y.T., et al. Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study) Nutrients. 2023;15:1982. doi: 10.3390/nu15081982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15081982</ArticleId><ArticleId IdType="pmc">PMC10143994</ArticleId><ArticleId IdType="pubmed">37111201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Xu Z., Mak J.W.Y., Chow K.M., Lui G., Li T.C.M., Wong C.K., Chan P.K.S., Ching J.Y.L., Fujiwara Y., et al. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study. J. Gastroenterol. Hepatol. 2022;37:823&#x2013;831. doi: 10.1111/jgh.15796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15796</ArticleId><ArticleId IdType="pmc">PMC9115073</ArticleId><ArticleId IdType="pubmed">35170078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>